ARSUF
Price
$20.03
Change
-$0.82 (-3.93%)
Updated
Oct 29 closing price
Capitalization
1.79B
GENPF
Price
$0.01
Change
-$0.03 (-75.00%)
Updated
Jun 6 closing price
Capitalization
1.29M
Interact to see
Advertisement

ARSUF vs GENPF

Header iconARSUF vs GENPF Comparison
Open Charts ARSUF vs GENPFBanner chart's image
Fagron SA
Price$20.03
Change-$0.82 (-3.93%)
Volume$425
Capitalization1.79B
GENIX PHARMACEUTICALS
Price$0.01
Change-$0.03 (-75.00%)
Volume$12K
Capitalization1.29M
ARSUF vs GENPF Comparison Chart in %
Loading...
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARSUF vs. GENPF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSUF is a Hold and GENPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ARSUF: $20.03 vs. GENPF: $0.01)
Brand notoriety: ARSUF and GENPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ARSUF: 100% vs. GENPF: 100%
Market capitalization -- ARSUF: $1.79B vs. GENPF: $1.29M
ARSUF [@Pharmaceuticals: Generic] is valued at $1.79B. GENPF’s [@Pharmaceuticals: Generic] market capitalization is $1.29M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARSUF’s FA Score shows that 1 FA rating(s) are green whileGENPF’s FA Score has 0 green FA rating(s).

  • ARSUF’s FA Score: 1 green, 4 red.
  • GENPF’s FA Score: 0 green, 5 red.
According to our system of comparison, ARSUF is a better buy in the long-term than GENPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARSUF’s TA Score shows that 1 TA indicator(s) are bullish while GENPF’s TA Score has 2 bullish TA indicator(s).

  • ARSUF’s TA Score: 1 bullish, 0 bearish.
  • GENPF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, both ARSUF and GENPF are a good buy in the short-term.

Price Growth

ARSUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while GENPF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.01%, and the average quarterly price growth was +87.11%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARSUF($1.79B) has a higher market cap than GENPF($1.29M). ARSUF YTD gains are higher at: 0.000 vs. GENPF (-65.500). ARSUF has higher annual earnings (EBITDA): 171M vs. GENPF (64.1K). ARSUF has more cash in the bank: 89.3M vs. GENPF (4.3K). GENPF has less debt than ARSUF: GENPF (965K) vs ARSUF (403M). ARSUF has higher revenues than GENPF: ARSUF (919M) vs GENPF (1.07K).
ARSUFGENPFARSUF / GENPF
Capitalization1.79B1.29M139,208%
EBITDA171M64.1K266,771%
Gain YTD0.000-65.500-
P/E Ratio17.97N/A-
Revenue919M1.07K86,129,335%
Total Cash89.3M4.3K2,076,261%
Total Debt403M965K41,762%
FUNDAMENTALS RATINGS
ARSUF: Fundamental Ratings
ARSUF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARSUFGENPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
19%
Bullish Trend 4 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
19%
Bullish Trend 4 days ago
58%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSPTX6.160.04
+0.65%
Transamerica Small Cap Growth I3
TCIHX27.160.12
+0.44%
Nuveen International Eq Idx I
EKSYX6.220.02
+0.32%
Allspring Diversified Income Bldr Inst
PIBAX18.880.04
+0.21%
PGIM Balanced A
MCLRX16.35-0.06
-0.37%
BlackRock Advantage Large Cap Core Inv C

ARSUF and

Correlation & Price change

A.I.dvisor tells us that ARSUF and GENPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and GENPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
GENPF - ARSUF
23%
Poorly correlated
N/A
AVCNF - ARSUF
11%
Poorly correlated
+0.48%
BOIRF - ARSUF
1%
Poorly correlated
N/A
BIOVF - ARSUF
1%
Poorly correlated
N/A
ABSCF - ARSUF
0%
Poorly correlated
N/A
More

GENPF and

Correlation & Price change

A.I.dvisor tells us that GENPF and ARSUF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENPF and ARSUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENPF
1D Price
Change %
GENPF100%
N/A
ARSUF - GENPF
23%
Poorly correlated
N/A
IMCC - GENPF
12%
Poorly correlated
-3.90%
VPHIF - GENPF
2%
Poorly correlated
N/A
CLCFF - GENPF
2%
Poorly correlated
-1.46%
TRUFF - GENPF
1%
Poorly correlated
-0.35%
More